Protocol for diagnostic assessment of sentinel lymph node in breast pathology: A proposal of SIAPEC-IAP, regione piemonte;Protocollo di trattamento del linfonodo sentinella in patologia mammaria: Proposta della SIAPEC-IAP, regione piemonte

Pathologica

Volumn 98, Issue 3, 2006, Pages 167-170

  Pietribiasi, Francesca ^a   De Rosa, G ^b   Arisio, R ^c   Bagnato, R ^d   Ravarino, N ^e   Pavesi, M ^f   Canavese, G ^g   Castellano, I ^h   Sapino, A ^h  

^a S CROCE E CARLE HOSPITAL   (Italy)

^b CANDIOLO CANCER INSTITUTE   (Italy)

^c Osp S Anna di Torino   (Italy)

^d Ospedale Castelli Verbania   (Italy)

^e MAURIZIANO HOSPITAL   (Italy)

^f Ospedale S Spirito Casale Monferrato   (Italy)

^g Ospedale S Giovanni Vecchio   (Italy)

^h UNIVERSITY OF TURIN   (Italy)

Author keywords

Breast; Regional Protocol; Sentinel lymph node

Indexed keywords

ARTICLE; BIOPSY TECHNIQUE; BREAST CANCER; CLINICAL PROTOCOL; DIAGNOSTIC PROCEDURE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; INTRAOPERATIVE PERIOD; LYMPH NODE METASTASIS; MICROSCOPY; SENTINEL LYMPH NODE BIOPSY;

AXILLA; BREAST; BREAST DISEASES; BREAST NEOPLASMS; FEMALE; FROZEN SECTIONS; HUMANS; IMMUNOHISTOCHEMISTRY; ITALY; LYMPH NODE EXCISION; MEDICAL RECORDS; PRACTICE GUIDELINES; SENTINEL LYMPH NODE BIOPSY; TUMOR MARKERS, BIOLOGICAL;

EID: 33748712458     PISSN: 00312983     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Veronesi U, Paganelli G, Galimberti V, Viale G, Zurrida S, Bedoni M, et al. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph nodes. Lancet 1997;349:1864-7.
2. Giuliano AE, Jones RC, Brennen M, Statman R. Sentinel lymphadenectomy in breast cancer. J Clin Oncol 1997;15:2345-50.
3. Cserni G, Amendoeira I, Apostolikas N, Bellocq JP, Bianchi S, Boecker W, et al. Discrepancies in current practice of pathological evaluation of sentinel lymph nodes in breast cancer. Results of a questionnaire based survey by the European Working Group for Breast Screening Pathology. J Clin Pathol 2004;57:695-701.
4. Cserni G, Sapino A, Decker T. Discriminating between micrometastases and isolated tumor cells in a regional and institutional setting. Breast 2005 Oct 12.
5. Linehan DC, Hill AD, Akhurst T, Yeung H, Tran KN, Borgen PI, et al. Intradermal radiocolloid and intraparenchymal blue dye injection optimise sentinel node identification in breast cancer patients. Ann Surg Oncol 1999;6:450-4.
6. Viale G, Mastropasqua MG, Maiorano E, Mazzarol G. Pathologic examination of the axillary sentinel lymph nodes in patients with early-stage breast carcinoma: current and resolving controversies on the basis of the European Institute of Oncology experience. Virchows Arch 2005;24:1-7.
7. Wells CA, (ed.). Quality assurance guidelines for pathology in mammographic screening. Open biopsy and resection specimens. 4th Edition. Produced by the E.C. Working Group on Breast Screening Pathology (in press).
8. Cserni G. Expert opinion. Evaluation of sentinel lymph nodes in breast cancer. Histopathology 2005;46:697-706.
9. Cserni G, Bianchi S, Vezzosi V, Peterse H, Sapino A, Arisio R, et al. The value of cytokeratin immunohistochemistry in the evaluation of axillary sentinel lymph nodes in patients with lobular breast carcinoma. J Clin Pathol (in pubblicazione).
10. Singletary SE, Allred C, Ashley P, Bassett LW, Berry D, Bland KI, et al. Revision of the American Joint Committee on Cancer Staging System for Breast Cancer. J Clin Oncol 2002;20:3628-36.
11. Singletary SE, Greene FL, Sobin LH. Classification of isolated tumor cell: clarification of the 6th edition of the American Joint Committee on cancer Staging Manual. Cancer 2003;98:2740-1.
12. Singletary SE, Connolly JL. Breast Cancer Staging: Working with the Sixth Edition of the AJCC Cancer Staging Manual. CA Cancer J Clin 2006;56:37-47.
13. Viale G, Maiorano E, Pruneri G, Mastropasqua MG, Valentini S, Galimberti V, et al. Predicting the risk for additional axillary metastases in patients with breast carcinoma and positive sentinel lymph node biopsy. Ann Surg 2005;241:319-25.
14. Guenther JM, Hansen NM, DiFronzo LA, Giuliano AE, Collins JC, Grube BL, et al. Axillary dissection is not required for all patients with breast cancer and positive sentinel nodes. Arch Surg 2003;138:52-6.
15. Sapino A, Cassoni P, Zanon E, Fraire F, Croce S, Coluccia C, et al. Ultrasonographically-guided fine-needle aspiration of axillary lymph nodes: role in breast cancer management. Br J Cancer 2003;88:702-6.
16. Noguchi N. Current controversies concerning sentinel lymph node biopsy for for breast cancer. Breast Cancer Res Treat 2004;84:261-71.
17. Luman GH, Giuliano AE, Somerfield MR, Benson III ALB, Bodurka DC, Burstein HJ, et al. American Society of Clinical Oncology Guideline Recommendations for Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer. J Clin Oncol 2005;23:7703-20.